Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 49,087 | 61,549 | 49,301 | 59,733 | 21,006 |
| Cost of Goods | 3,527 | 5,554 | 3,341 | 2,453 | 1,202 |
| Gross Profit | 45,560 | 55,995 | 45,960 | 57,280 | 19,804 |
| Operating Expenses | 126,623 | 137,891 | 104,238 | 102,654 | 113,937 |
| Operating Income | -80,536 | -81,342 | -57,937 | -44,921 | -93,931 |
| Other Income | -2,651 | 4,045 | 4,407 | 5,002 | 6,546 |
| Pre-tax Income | -83,187 | -77,297 | -53,530 | -39,919 | -87,385 |
| Net Income Continuous | -83,187 | -77,297 | -53,530 | -39,919 | -87,385 |
| Net Income | $-83,187 | $-77,297 | $-53,530 | $-39,919 | $-87,385 |
| EPS Basic Total Ops | -1.11 | -1.04 | -0.72 | -0.54 | -1.18 |
| EPS Basic Continuous Ops | -1.11 | -1.04 | -0.72 | -0.54 | -1.18 |
| EPS Diluted Total Ops | -1.11 | -1.04 | -0.72 | -0.54 | -1.18 |
| EPS Diluted Continuous Ops | -1.11 | -1.04 | -0.72 | -0.54 | -1.18 |
| EPS Diluted Before Non-Recurring Items | -1.11 | -1.04 | -0.72 | -0.54 | -1.18 |
| EBITDA(a) | $-79,435 | $-80,325 | $-57,059 | $-44,077 | $-93,202 |